88 Chapter 4 47. Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. The journal of pain : official journal of the American Pain Society. 2008;9(2):105–21. 48. Bussmann H. Validation of the Active8 Activity Monitor: detection of body postures and movements. Rotterdam; 2013. 49. Activ8 Physical Activity Monitor. [cited 2019 Mar 18]. Available from: https://www.Active8all.com 50. Newman-Beinart NA, Norton S, Dowling D, Gavriloff D, Vari C, Weinman JA, et al. The development and initial psychometric evaluation of a measure assessing adherence to prescribed exercise: the Exercise Adherence Rating Scale (EARS). Physiotherapy. 2017;103(2):180–5. 51. Arensman RM, Geelen RH, Koppenaal T, Veenhof C, Pisters MF. Measuring exercise adherence in patients with low back pain: development, validity, and reliability of the EXercise Adherence Scale (EXAS). Physiother Theory Pract. 2022;38(7):928–37. 52. Waddell G, Newton M, Henderson I, Somerville D, Main CJ. A Fear-Avoidance Beliefs Questionnaire (FABQ) and the role of fear-avoidance beliefs in chronic low back pain and disability. Pain. 1993;52(2):157–68. 53. van Damme S. Catastroferen over pijn: pain Catastrophizing scale-Dutch version (PCS-DV). Gent, Belgium: Universiteit Gent; 2002. 54. Sullivan MJL, Bishop SR, Pivik J. The Pain Catastrophizing Scale: Development and validation. Psychol Assess. 1995;7(4):524–32. 55. Bandura A. Self-efficacy. In: Ramachaudran VS, editor. Encyclopedia of human behavior. New York: Academic Press; 1994. p. 71–81. 56. Schwarzer R, Jerusalem M. Causal and Control Beliefs. In: Measures in Health Psychology: A User’s Portfolio. 1995. p. 35–7. 57. Teeuw B, Schwarzer R, Jerusalem M. Dutch Adaptation of the General Self-Efficacy Scale. 1994. Available from: https://userpage.fu-berlin.de/~health/dutch.htm 58. Scholz U, Doña BG, Sud S, Schwarzer R. Is General Self-Efficacy a Universal Construct? Psychometric findings from 25 countries. Eur J Psychol Assess. 2002;18(3):242–51. 59. Hibbard JH, Mahoney ER, Stockard J, Tusler M. Development and Testing of a Short Form of the Patient Activation Measure. Health Serv Res. 2005;40(6p1):1918–30. 60. Rademakers J, Nijman J, van der Hoek L, Heijmans M, Rijken M. Measuring patient activation in The Netherlands: translation and validation of the American short form Patient Activation Measure (PAM13). BMC Pub Health. 2012;12(1):577. 61. Vet H De, Heymans MW, Dunn KM, Pope D. Episodes of Low Back Pain: A Proposal for Uniform Definitions to Be Used in Episodes of Low Back Pain A Proposal for Uniform Definitions to Be Used in Research. Spine. 2002;27(21):2409–16. 62. Campbell MK, Piaggio G, Elbourne DR, Altman DG. Consort 2010 statement: extension to cluster randomised trials. BMJ. 2012;345:e5661–e5661. 63. Sedgwick P. Cluster randomised controlled trials: sample size calculations. BMJ. 2013;346:f2839–f2839. 64. Vickers AJ. How many repeated measures in repeated measures designs? Statistical issues for comparative trials. BMC Med Res Methodol. 2003;3(1):22.
RkJQdWJsaXNoZXIy MTk4NDMw